Stay updated on VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.

Latest updates to the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision: v3.4.3 was added to the documentation and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2, a minor backend/UI update that does not modify study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check57 days agoChange DetectedA new revision label 'Revision: v3.4.1' was added and the previous label 'Revision: v3.4.0' was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check71 days agoChange DetectedShow glossary toggle added; capitalization standardized for 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. Revision updated to v3.4.0 (from v3.3.4).SummaryDifference0.1%

- Check78 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3.SummaryDifference0.0%

Stay in the know with updates to VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.